Aurora Cannabis (ACB) Set to Announce Quarterly Earnings on Tuesday

Aurora Cannabis (NYSE:ACB) is scheduled to be releasing its earnings data after the market closes on Tuesday, May 14th. Analysts expect Aurora Cannabis to post earnings of ($0.03) per share for the quarter.

Aurora Cannabis (NYSE:ACB) last issued its quarterly earnings results on Monday, February 11th. The company reported ($0.04) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.06) by $0.02. The business had revenue of $41.00 million during the quarter. Aurora Cannabis had a negative net margin of 57.54% and a positive return on equity of 3.95%. On average, analysts expect Aurora Cannabis to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of NYSE:ACB opened at $8.35 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.31 and a quick ratio of 2.50. The company has a market capitalization of $8.47 billion, a P/E ratio of 69.58 and a beta of 2.82. Aurora Cannabis has a 52 week low of $4.05 and a 52 week high of $12.52.



A hedge fund recently bought a new stake in Aurora Cannabis stock. Geode Capital Management LLC purchased a new position in shares of Aurora Cannabis Inc (NYSE:ACB) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 107,728 shares of the company’s stock, valued at approximately $515,000. Hedge funds and other institutional investors own 9.04% of the company’s stock.

Several brokerages recently commented on ACB. ValuEngine upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Tuesday, March 19th. TheStreet upgraded shares of Aurora Cannabis from a “d+” rating to a “c” rating in a research report on Thursday, April 4th. Desjardins assumed coverage on shares of Aurora Cannabis in a research report on Thursday, April 25th. They issued a “buy” rating and a $9.07 target price for the company. Bank of America assumed coverage on shares of Aurora Cannabis in a research report on Wednesday, April 17th. They issued a “buy” rating and a $11.00 target price for the company. Finally, GMP Securities upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Wednesday, March 13th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $9.86.

TRADEMARK VIOLATION WARNING: “Aurora Cannabis (ACB) Set to Announce Quarterly Earnings on Tuesday” was first posted by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://dakotafinancialnews.com/2019/05/12/aurora-cannabis-acb-set-to-announce-quarterly-earnings-on-tuesday.html.

Aurora Cannabis Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Read More: What is the Book Value of a Share?

Earnings History for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.